Darren E. Insko

2.6k total citations
2 papers, 29 citations indexed

About

Darren E. Insko is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Darren E. Insko has authored 2 papers receiving a total of 29 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Hematology, 1 paper in Molecular Biology and 1 paper in Genetics. Recurrent topics in Darren E. Insko's work include Chronic Myeloid Leukemia Treatments (2 papers), Acute Myeloid Leukemia Research (1 paper) and Multiple Myeloma Research and Treatments (1 paper). Darren E. Insko is often cited by papers focused on Chronic Myeloid Leukemia Treatments (2 papers), Acute Myeloid Leukemia Research (1 paper) and Multiple Myeloma Research and Treatments (1 paper). Darren E. Insko collaborates with scholars based in United States. Darren E. Insko's co-authors include Patrick P. Zarrinkar, Robert C. Armstrong, Wendell Wierenga, Sunny Abraham, Gang Liu, Michael F. Gardner, Mark W. Holladay, Shimin Xu, Xing Liu and Daniel Brigham and has published in prestigious journals such as Blood and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Darren E. Insko

2 papers receiving 28 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Darren E. Insko United States 2 13 13 11 9 7 2 29
Jianshe Kong United States 4 28 2.2× 13 1.0× 5 0.6× 5 0.7× 6 45
Joerg Trappe Switzerland 3 16 1.2× 2 0.2× 2 0.2× 4 0.4× 24 3.4× 4 35
Stephanie Lehmann Germany 3 11 0.8× 5 0.4× 6 0.7× 29 4.1× 4 42
Justin J. Ellis United States 2 3 0.2× 12 0.9× 6 0.7× 24 3.4× 4 33
Todd Minga Germany 3 2 0.2× 24 1.8× 5 0.6× 5 0.7× 9 33
Adrienne J. Burns United States 3 8 0.6× 4 0.3× 2 0.2× 8 1.1× 6 21
Lindsay Westlake United States 3 4 0.3× 3 0.2× 3 0.3× 23 3.3× 3 31
Julia Lohman United States 2 16 1.2× 4 0.4× 8 1.1× 3 27
Sari E. Jalkanen Finland 2 1 0.1× 14 1.1× 10 1.1× 6 0.9× 3 19
Crystal McKinnon 2 13 1.0× 2 0.2× 11 1.6× 2 27

Countries citing papers authored by Darren E. Insko

Since Specialization
Citations

This map shows the geographic impact of Darren E. Insko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darren E. Insko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darren E. Insko more than expected).

Fields of papers citing papers by Darren E. Insko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Darren E. Insko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darren E. Insko. The network helps show where Darren E. Insko may publish in the future.

Co-authorship network of co-authors of Darren E. Insko

This figure shows the co-authorship network connecting the top 25 collaborators of Darren E. Insko. A scholar is included among the top collaborators of Darren E. Insko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darren E. Insko. Darren E. Insko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

2 of 2 papers shown
1.
Liu, Gang, Sunny Abraham, Xing Liu, et al.. (2015). Discovery and optimization of a highly efficacious class of 5-aryl-2-aminopyridines as FMS-like tyrosine kinase 3 (FLT3) inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(17). 3436–3441. 16 indexed citations
2.
James, Joyce, Keith W. Pratz, Adam Stine, et al.. (2008). Clinical Pharmacokinetics and FLT3 Phosphorylation of AC220, a Highly Potent and Selective Inhibitor of FLT3. Blood. 112(11). 2637–2637. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026